MarketWatch: Health Round-up
Pages: 60
Publisher: Datamonitor
Date Published: August 2006
Format: PDF
Price: $400
Overview
Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.
Table of Contents
In this month’s MarketWatch…
Pharmaceutical Company Round-up
Page 3
Cancer Update
Page 4 – News Round-up
Page 7 – Opinion: ChemGenex: positive data unlikely to guarantee Ceflatonin success…
Page 7 – Opinion: Genentech/Roche: Avastin success in pancreatic cancer on hold?
Page 8 – Opinion: Roche: Avastin continues to march on…
Page 10 – Feature Analysis: Roche/Genentech making strides
Cardiovascular Update
Page 11 – News Round-up
Page 14 – Opinion: Hypertension: beta-blockers to be moved to the back shelves…
Page 14 – Opinion: AstraZeneca: more lipid liaisons…
Page 15 – Opinion: Bristol-Myers Squibb/Sanofi-Aventis: Plavix deal under threat…
Page 16 – Opinion: Takeda: hypertension hurdles…
Page 17 – Feature Analysis: Antiarrhythmics: RSD1235 woes reduce market potential but not clinical impact…
CNS Update
Page 19 – News Round-up
Page 21 – Opinion: Biogen Idec/Elan: a new market for Tysabri…
Page 21 – Opinion: Pfizer: Chantix stubs out GlaxoSmithKline’s Zyban…
Page 22 – Opinion: Teva/Eisai: the end of an alliance …
Page 24 – Feature Analysis: Urinary incontinence: common problem, not commonly reported…
IDI Update
Page 26 – News Round-up
Page 29 – Opinion: EULAR: Roche and BMS target RA market…
Page 29 – Opinion: Santarus: Zegerid to act fast on revenues…
Page 31 – Feature Analysis: Symbicort and Seretide’s battle for the respiratory market…
Infectious Diseases Update
Page 33 – News Round-up
Page 36 – Feature Analysis: Tibotec and J&J cleared to launch Aptivus rival…
Page 37 – Feature Analysis: PowderMed: flying ahead in avian flu …
Company Spotlight
Page 39 – Sanofi-Aventis
Biotechnology Update
Page 46 – Biotech News Round-up
Page 48 – Opinion: TeGenero: bankruptcy beckons…
Page 49 – Feature Analysis: Biologics driving growth to 2010…
Company Spotlight
Page 51 – MedImmune Inc
Index
Page 59 – Pharma companies
Page 59 – Biotech companies
Page 60 – Key drugs
